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When validating risk models (or probabilistic classiﬁers), calibration is often overlooked. Calibration
refers to the reliability of the predicted risks, i.e. whether the predicted risks correspond to observed
probabilities. In medical applications this is important because treatment decisions often rely on the
estimated risk of disease. The aim of this paper is to present generic tools to assess the calibration of
multiclass risk models.
We describe a calibration framework based on a vector spline multinomial logistic regression model.
This framework can be used to generate calibration plots and calculate the estimated calibration index
(ECI) to quantify lack of calibration. We illustrate these tools in relation to risk models used to character-
ize ovarian tumors. The outcome of the study is the surgical stage of the tumor when relevant and the
ﬁnal histological outcome, which is divided into ﬁve classes: benign, borderline malignant, stage I, stage
II–IV, and secondary metastatic cancer. The 5909 patients included in the study are randomly split into
equally large training and test sets. We developed and tested models using the following algorithms:
logistic regression, support vector machines, k nearest neighbors, random forest, naive Bayes and nearest
shrunken centroids.
Multiclass calibration plots are interesting as an approach to visualizing the reliability of predicted
risks. The ECI is a convenient tool for comparing models, but is less informative and interpretable than
calibration plots. In our case study, logistic regression and random forest showed the highest degree of
calibration, and the naive Bayes the lowest.
 2015 Elsevier Inc. All rights reserved.1. Introduction
For medical applications, prediction models that provide
probabilistic (risk) estimates of an event of interest are usefulfor clinical decision support, personalized healthcare, and shared
decision making. Prior to the implementation of such tools in clin-
ical practice, validation with respect to discrimination and
calibration is required [1–6]. A model should be able to distin-
guish between different possible outcome categories (discrimina-
tion). This can be evaluated using the area under the receiver
operating characteristic curve (AUC) or multiclass extensions of
this approach. Calibration assessment is often overlooked, but is
of importance for several applications where risk models may
be used. Such applications include decisions whether or not to
treat a patient [7], start preventive action, or to inform the choice
of treatment [8]. Calibration is also relevant when informing
patients about risk [9], when comparing hospitals with respect
to quality of care (e.g. benchmarking based on mortality risk)
[10], and when identifying high risk patients for inclusion in clin-
ical trials [11]. The optimal use of risk models in these situations
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from decision analysis states that the adopted risk threshold to
decide whether or not to take further action implies speciﬁc
misclassiﬁcation costs [12]: the odds of the risk threshold equals
the ratio of the harm of a false positive test result to the beneﬁt of
a true positive result. For example if a risk threshold of 10% is
adopted, the assumption is that 1 true positive is worth 9 false
positives. If a poorly calibrated risk model is then used to assess
whether patients exceed the planned threshold, inappropriate
decisions may be taken.
For binary outcomes, the relationship between predicted and
observed probabilities can be visualized by means of a calibration
plot [1,13,14]. Observed probabilities are sometimes obtained by
computing event rates within groups of patients with similar pre-
dicted probabilities (e.g. decile split). However, often ﬂexible
smoothing methods such as local regression (loess) or splines are
used to link predicted probabilities to estimated observed prob-
abilities [1].
Recently, our group extended binary calibration plots to multi-
class models based on multinomial logistic regression (MLR) [15].
We proposed two frameworks, one parametric and one non-para-
metric. Logistic regression is a common algorithm to build binary
and multiclass clinical prediction models, and naturally works with
risk estimates. However, machine learning algorithms are also
used for clinical risk prediction [16–21], and are very frequently
used in high dimensional and/or ‘‘large p, small n’’ prediction stud-
ies (i.e. a large number of predictors and a small number of
patients) [22–24]. Moreover, although using machine-learning
approaches for classiﬁcation problems is often less suited to prob-
ability estimation, methods do exist to facilitate this [25–30]. The
calibration performance of risk models is an issue that is often
neglected, and it is not surprising that with a few exceptions this
is frequently the case for models based on machine learning algo-
rithms [13,26,27,30–32].
The aim of this paper is to introduce a non-parametric frame-
work to evaluate the calibration of multiclass risk models irrespec-
tive of the modeling technique used. Based on this framework we
also derive a calibration measure to quantify and compare calibra-
tion performance between models. We illustrate these methods
with a case study looking at the classiﬁcation of ovarian tumors.
We develop and validate risk models to diagnose tumor pathology
based on logistic regression, support vector machines, k-nearestTable 1
Descriptive statistics of the ovarian tumor case study.
Benign Borderlin
Outcome, N 3980 339
Variable, N (%) or median (IQR)
Age (years) 42 (32–54) 49 (36–62
Serum CA125 (U/mL)a 19 (11–39) 31 (16–10
Family history of ovarian cancer 79 (2.0) 10 (3.0)
Maximal diameter of lesion (mm) 63 (45–87) 86 (51–15
Solid tissue
Presence of solid tissue 1322 (33.2) 267 (78.8
Proportion solid tissue if present (%) 42 (20–100) 37 (24–59
Number of papillary projections
None 3424 (86.0) 135 (39.8
1 333 (8.4) 69 (20.4)
2 80 (2.0) 21 (6.2)
3 66 (1.7) 24 (7.1)
>3 77 (1.9) 90 (26.5)
More than 10 cyst locules 199 (5.0) 74 (21.8)
Acoustic shadows 676 (17.0) 8 (2.4)
Ascites 64 (1.6) 28 (8.3)
Missing values for CA125, N (%) 1447 (36.4) 62 (18.3)
Abbreviations: IQR; InterQuartile Range.
a Results for Serum CA125 are based on single imputation of missing values.neighbors, random forest, naive Bayes and nearest shrunken
centroids.
2. Non-parametric recalibration framework
Our group developed calibration tools for risk models based on
multinomial logistic regression (MLR) [15]. Assume an MLR or
‘baseline-category logit’ model [33] with m predictors x1 to xm
for an outcome with J (j = 1, . . . , J) categories. If category 1 is chosen
as the reference category, the model is written as
log P Y¼2ð ÞP Y¼1ð Þ
h i
¼ a2 þ
Pm
l¼1b2lxl ¼ lp21
log P Y¼3ð ÞP Y¼1ð Þ
h i
¼ a3 þ
Pm
l¼1b3lxl ¼ lp31
. . .
log P Y¼Jð ÞP Y¼1ð Þ
h i
¼ aJ þ
Pm
l¼1bJlxl ¼ lpJ1
8>>>><
>>>:
ð1Þ
and the multiclass risks are obtained as
P Y ¼ 1ð Þ ¼ p1 ¼ 11þexpðlp21Þþexpðlp31ÞþþexpðlpJ1Þ ¼ 11þPJ
j¼2 expðlpj1Þ
P Y ¼ 2ð Þ ¼ p2 ¼ expðlp21Þ1þexpðlp21Þþexpðlp31ÞþþexpðlpJ1Þ ¼
expðlp21Þ
1þ
PJ
j¼2 expðlpj1Þ
. . .
P Y ¼ Jð Þ ¼ pJ ¼ expðlpJ1Þ1þexpðlp21Þþexpðlp31ÞþþexpðlpJ1Þ ¼
expðlpJ1Þ
1þ
PJ
j¼2 expðlpj1Þ
8>>>><
>>>>:
ð2Þ
Let l^p21; . . . ; l^pJ1
n o
denote the estimated linear predictors and
p^1; . . . ; p^J
 
the estimated multiclass risks. The non-parametric
recalibration framework for such models relates the multiclass out-
come Y on the estimated J  1 linear predictors l^p21; . . . ; l^pJ1
n o
from
the MLR risk model through a vector spline [34] MLR analysis [15]:
log PðY ¼ 2Þ=PðY ¼ 1Þ½  ¼ a2 þ
PJ
j¼2 b2j  s2 l^pj1
  
log P Y ¼ 3ð Þ=P Y ¼ 1ð Þ½  ¼ a3 þ
PJ
j¼2 b3j  s3 l^pj1
  
. . .
log P Y ¼ Jð Þ=P Y ¼ 1ð Þ½  ¼ aJ þ
PJ
j¼2 bJj  sJ l^pj1
  
8>>>><
>>>>:
ð3Þ
with sðÞ ¼ s2ðÞ; s3ðÞ; . . . ; sJðÞ
 
a vector spline smoother applied to
each linear predictor [15,34]. This vector spline smoother sðÞ is a nat-
ural extension of the cubic spline smoother to vector responses ande Stage I Stage II–IV Metastatic
356 988 246
) 54 (44–64) 59 (50–67) 57 (47–68)
0) 52 (21–190) 447 (147–1215) 81 (30–271)
13 (3.7) 57 (5.8) 5 (2.0)
0) 106 (71–153) 85 (56–123) 86 (56–124)
) 328 (92.1) 968 (98.0) 234 (95.1)
) 61 (38–100) 100 (56–100) 100 (64–100)
) 227 (63.8) 772 (78.1) 213 (86.6)
25 (7.0) 56 (5.7) 12 (4.9)
17 (4.8) 30 (3.0) 0 (0)
17 (4.8) 28 (2.8) 2 (0.8)
70 (19.7) 102 (10.3) 19 (7.7)
69 (19.4) 93 (9.4) 36 (14.6)
18 (5.1) 30 (3.0) 10 (4.1)
65 (18.3) 473 (47.9) 90 (36.6)
71 (19.9) 163 (16.5) 62 (25.2)
K. Van Hoorde et al. / Journal of Biomedical Informatics 54 (2015) 283–293 285consists of J  1 natural cubic B-splines sjðÞ [34,35]. Similarly as the
multiclass risks in (2) are obtained from (1), this framework can be
used to estimate the observed probabilities o^1; . . . ; o^J
 
(Appendix
A) [15].
If we now consider a generic multiclass risk model (i.e. irrespec-
tive of how it was developed) yielding risk estimates p^1; . . . ; p^J
 
. In
order to use the nonparametric recalibration model we ﬁrst calcu-
late log p^j=p^1
 	 ¼ z^j1, with j = 2, . . . , J if category 1 is used as refer-
ence category. These quantities are used as predictors in the
vector spline MLR model (3) to estimate the observed
probabilities:
log PðY ¼ 2Þ=PðY ¼ 1Þ½  ¼ a2 þ
PJ
j¼2b2j  s2 z^j1
 	
log PðY ¼ 3Þ=PðY ¼ 1Þ½  ¼ a3 þ
PJ
j¼2b3j  s3 z^j1
 	
. . .
log PðY ¼ JÞ=PðY ¼ 1Þ½  ¼ aJ þ
PJ
j¼2bJj  sJ z^j1
 	
8>><
>>>:
ð4Þ
The observed probabilities o^j are obtained by using the vector spline
MLR model (4) and then applying the equations like (2) (Appendix
A). Calibration plots are obtained by plotting the predicted probabil-
ities p^j vs the observed probabilities o^j for each outcome category
jðj ¼ 1; . . . ; JÞ [15]. Note that there is no one-to-one relationship
between p^j and o^j. The reason is that, for a speciﬁc value of p^j, pre-
dicted probabilities for the other J  1 categories can vary and this
will lead to different values for o^j. Therefore, spline smoothers are
plotted to assess the trend of the scatter plot for each category [15].
To quantify the lack of calibrationwith a singlemeasure, the cor-
respondence between p^j and o^j can be assessed through their
squared difference averaged over J categories and N observations:
PN
n¼1
PJ
j¼1 p^nj  o^nj
 	2h i. N  Jð Þ. If we multiply the average squared
difference by 100J/2we obtain ameasure thatwe refer to as the esti-
mated calibration index (ECI) because it is based on estimates of the
observed probabilities o^1; . . . ; o^J
 
. The multiplication factor 100J/2
ensures that the ECI has a theoretical range between 0 and 100
(Appendix B). The ECI has similarities to the Brier score. However,
the Brier score represents the average squared difference between
the actual outcomes yn and the predicted probabilities such that it
is an overall performance measure that captures discrimination
and calibration: Brier score =
PN
n¼1
PJ
j¼1 ynj  p^nj
 	2h i. N  Jð Þ [36].
In contrast, the ECI is the average squared difference of the predicted
probabilities p^n with the estimated observed probabilities o^n instead
of the actual outcomes.3. Case-study
The accurate diagnosis of ovarian tumors prior to surgery is cru-
cial when choosing appropriate patient management and referral.
As different types of malignancies require different management,
we aimed to develop a model to predict the risk that an ovarian
tumor is benign, borderline malignant, a stage I cancer, a stage
II–IV cancer, or secondary metastatic cancer. We used data fromTable 2
Overview of the binary and multiclass approaches considered.
Binary Multiclass
All-at-once Binary tree Pairwise coupling
LR MLR LR-BT LR-PC
SVM – SVM-BT SVM-PC
KNN KNN – –
RF RF – –
NB NB – –
NSC NSC – –the International Ovarian Tumor Analysis (IOTA) consortium [37–
39]. These data are derived from 5909 patients collected between
1999 and 2012 at 24 centers in 10 countries [40], and were ran-
domly divided into a development and validation set stratiﬁed
for the ﬁnal outcome. The outcome is based on the histo-patholog-
ical diagnosis of the mass after surgical removal by laparotomy or
laparoscopy as well as the stage of the tumor (when relevant) as
assessed by the surgeon. Pathologists were blind to the data col-
lected for the study and the results of any risk models we devel-
oped. The following predictors or features were considered for
model development without further selection: age (years), serum
CA125 (U/ml), oncology referral center (yes/no), maximum diame-
ter of the lesion (mm), proportion of solid tissue (between 0 and 1),
presence of more than 10 cyst locules (yes/no), number of papillary
projections (0, 1, 2, 3 and more than 3), presence of acoustic shad-
ows (yes/no) and presence of ascites (yes/no) (Table 1). The pro-
portion of solid tissue is deﬁned as the ratio of the maximum
diameter of the largest solid component and the maximum diam-
eter of the lesion. These nine variables are the predictors from the
multinomial risk prediction model ADNEX [40]. Some values for
serum CA125 were missing and were imputed in order not to lose
these records. We used predictive mean matching regression [41]
using variables that were either related to the level of CA125 itself,
or the unavailability of CA125 via an indicator as to whether the
CA125 level was missing or not [42].3.1. Study set-up
We develop and validate various binary and multiclass risk
models to diagnose ovarian tumors. The models are based on logis-
tic regression and machine learning algorithms (see Appendix C).
In the ﬁrst part of the study, we develop binary models to distin-
guish between benign and malignant tumors. We then discuss
multiclass problems by developing models to distinguish between
benign, borderline malignant, stage I invasive, stage II–IV invasive
and secondary metastatic ovarian tumors. The available data were
split into a development set and a validation set. The split was
random, using a 1:1 ratio with stratiﬁcation according to the
multiclass outcome. R version 3.0.3 (www.r-project.org) was used
for the statistical analysis.3.2. Performance evaluation
The ability to distinguish between different outcome categories
(discrimination) as well as the reliability of predicted risks (calibra-
tion) is assessed.3.2.1. Discrimination
Discrimination of a binary risk prediction model was evaluated
using the area under the ROC curve (AUC) [43]. For the multiclass
risk models, several measures were used that are related to the
AUC. First, we calculated AUCs for pairs of categories based on con-
ditional risks (e.g. riskA/(riskA þ riskB), where riskA and riskB are the
estimated risks for categories A and B) [44]. Two multiclass AUCs
variants were also evaluated: the M-index and Polytomous Dis-
crimination Index (PDI) [45,46]. The M-index is an average of pair-
wise AUCs, where the pairwise AUC for categories A and B is the
average of the AUC based on riskA and the AUC of riskB (these
two AUCs are not the same because riskA þ riskB – 1) [45]. The
PDI is a direct multiclass version of the AUC and estimates the
average proportion of correctly identiﬁed cases within a group of
cases each belonging to a different outcome category [46]. For J
outcome categories the value of M-index and PDI for a model that
gives random predictions is 0.5 and 1/J (e.g. 0.2 if J = 5) [46].
Fig. 1. The three different considered sequential dichotomous models or binary trees.
Table 3
Discrimination (AUC) and calibration (mean calibration (in %) of the risk of
malignancy and estimated calibration index (ECI)) performance of the binary
prediction models on the validation data.
Model (selection criterion) Discrimination Calibration
AUC Mean calibration ECI
LR 0.938 0.25 0.01
SVM (accuracy) 0.940 0.94 0.09
SVM (logloss) 0.945 0.40 0.04
kNN (accuracy) 0.860 1.80 0.61
kNN (logloss) 0.862 1.92 0.05
RF (accuracy) 0.948 1.64 0.05
RF (logloss) 0.948 1.64 0.05
NB (accuracy) 0.910 3.93 1.67
NB (logloss) 0.910 3.93 1.67
NSC (accuracy) 0.890 2.47 0.45
NSC (logloss) 0.890 2.47 0.45
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As an overall group-level measure we calculated the calibra-
tion-in-the-large or mean calibration for every outcome category.
This measure equates to the difference between the observed
event rate of an outcome category and the average predicted prob-
ability of this category (i.e. the predicted event rate). For the
assessment of the calibration of individual risk predictions we used
the non-parametric recalibration framework explained in Section 2
to produce calibration plots and to calculate ECI.3.3. Overview of the implemented approaches
In the ﬁrst part of the study we focus on the binary diagnosis of
ovarian tumors as benign or malignant. The binary risk models
were logistic regression, support vector machines, k nearest neigh-
bors, random forest, naive Bayes and nearest shrunken centroids
[47–51] (Table 2). More information concerning the different mod-
els and the tuning of the hyperparameters is given in Appendix C.
In the second part we focus on the multiclass diagnosis of ovar-
ian tumors as benign, borderline malignant, stage I cancer, stage II–
IV cancer, or secondary metastatic cancer. Multiclass risk models
can either be a combination of binary risk models or an ‘all-in-
one’ model. Among the algorithms we implemented, only the
SVMs could not give all-in-one multiclass risks. When binary mod-
els were combined, two types of combinations were used: a tree of
nested dichotomies (or binary tree) [52], and pairwise coupling
[53]. For the former a tree of binary prediction models is con-
structed. In our case study, from a clinical viewpoint the ﬁrst two
dichotomies of the binary tree are straightforward: ﬁrst a modelto distinguish between benign and malignant tumors, then for
the malignant tumors a model to distinguish between borderline
and invasive tumors. The invasive tumor category has three sub-
groups: stage I, stage II–IV and secondary metastatic cancers. Since
it is less obvious what the most clinically relevant tree is for these
three categories, we constructed three possible trees and com-
puted the average (Fig. 1). For pairwise coupling, the pairwise
probabilities p^ij of every pairwise model i vs j are combined in
order to obtain multiclass probabilities p^i (i = 1, . . . , J) by solving
the following system: pi ¼
PJ
j¼1;j–i pi þ pj
 	
=J  1 p^ij, for all i withPJ
i¼1pi ¼ 1 and pi P 0 [54].
For multiclass risk prediction, we applied nine algorithms
(Table 2). For logistic regression, all-in-one multinomial logistic
regression (MLR), sequential dichotomous logistic regression (LR-
BT) and pairwise coupling logistic regression (LR-PC) were used.
For support vector machines, a binary tree (SVM-BT) and a pair-
wise coupling (SVM-PC) approach were applied.3.4. Model comparison based on ECI
Conﬁdence intervals for ECI and the ECI difference between two
models were obtained with bootstrapping using the bias-corrected
method on 1000 bootstrap samples of the validation data. We
always reported 95% conﬁdence intervals, however we used the
following procedure to test for differences between models with
respect to calibration. We ranked the models based on their valida-
tion data ECI, and compared the best model with every other
model. A correction for multiple testing was used using a method
similar to the Holm step-down method. We compared the best
model with the worst model using a = 0.05/(m  1), where m is
the number of models. If signiﬁcant, the best model is compared
with the second to worst model using a = 0.05/(m  2), and so
on. Once a test is not statistically signiﬁcant, all remaining tests
are considered not signiﬁcant as well.3.5. Software
For the logistic regression and machine learning models we
used the following R-packages: rms, vgam, klaR, pamr, random-
Forest, kernlab and caret. The function sigest() of the R-
package kernlab is used for automatic sigma estimation, while
the functions train() and trainControl() of the R-package
caret were used for the determination of optimal tuning
parameters.
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Fig. 2. Binary calibration plot of the validation data for (a) binary logistic regression, (b) binary naïve Bayes, (c) k nearest neighbors with maximizing accuracy and (d)
minimizing logloss as selection criterion.
Table 4
Discrimination, i.e. M-index and Polytomous Discrimination Index PDI, for the
multiclass prediction models using the validation data.
Model (selection criterion) Discrimination Calibration
M-index PDI ECI (95%CI)
MLR 0.790 0.529 0.27 [0.13;0.36]
LR-BT 0.798 0.542 0.30 [0.18;0.38]
LR-PC 0.795 0.537 0.26 [0.18;0.32]
SVM-BT (acc) 0.755 0.482 0.51 [0.31;0.61]
SVM-BT (ll) 0.770 0.505 0.38 [0.26;0.48]
SVM-PC (acc) 0.764 0.467 0.76 [0.59;0.87]
SVM-PC (ll) 0.764 0.469 0.81 [0.64;0.93]
kNN (acc) 0.684 0.403 0.76 [0.56;0.94]
kNN (ll) 0.686 0.399 0.28 [0.18;0.33]
RF (acc) 0.792 0.539 0.40 [0.23;0.48]
RF (ll) 0.792 0.539 0.40 [0.23;0.48]
NB (acc) 0.742 0.451 8.25 [7.66;8.76]
NB (ll) 0.768 0.495 4.82 [4.26;5.39]
NSC (acc) 0.754 0.470 1.42 [1.11;1.63]
NSC (ll) 0.753 0.471 1.19 [0.91;1.39]
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4.1. Binary outcome
The optimal hyperparameter values based on maximizing the
accuracy and minimizing the logloss were different for the SVM
regularization parameter C (10 based on accuracy vs 1 based on
logloss) and for the number of neighbors for kNN (20 vs 50). Min-
imizing the logloss resulted in a simpler model compared with
maximizing accuracy. This implies less over-ﬁtting and smoother
results, which means that better calibration performance can be
expected.
The validation AUCs demonstrated good discrimination for all
approaches (Table 3). kNN had the worst discriminative ability
with a validation AUC of 0.890, RF the best with a validation AUC
of 0.948.
The mean calibration of the risk of malignancy was close to zero
for logistic regression. Overall it ranged between 0.25% (logistic
regression) and 3.93% (naive Bayes) on the validation data suggest-
Table 5
Model comparison based on the difference in ECI (with 95% conﬁdence intervals)
using the validation data. In the ﬁrst part, the ECI of each model is compared with the
ECI of the best model (LR-PC). Models for which there is a statistically signiﬁcant
difference with LR-PC after correction for multiple testing are identiﬁed with an
asterisk. In the second part, the ECI values of each machine learning model with
hyperparameter tuning based on accuracy and logloss are compared.
Model comparison ECI (95% CI)
Each model vs the best (LR-PC)
MLR vs LR-PC 0.01 [0.05;0.07]
kNN (ll) vs LR-PC 0.02 [0.10;0.17]
LR-BT vs LR-PC 0.03 [0.02,0.10]
SVM-BT (ll) vs LR-PC 0.12 [0.01;0.24]
RF (acc) vs LR-PC 0.14 [0.02;0.29]
RF (ll) vs LR-PC 0.14 [0.02;0.29]
SVM-BT (acc) vs LR-PC 0.25 [0.09;0.40]⁄
kNN (acc) vs LR-PC 0.50 [0.28;0.75]⁄
SVM-PC (acc) vs LR-PC 0.49 [0.32;0.67]⁄
SVM-PC (ll) vs LR-PC 0.55 [0.37;0.72]⁄
NSC (ll) vs LR-PC 0.93 [0.72;1.15]⁄
NSC (acc) vs LR-PC 1.15 [0.94;1.40]⁄
NB (ll) vs LR-PC 4.55 [4.06;5.17]⁄
NB (acc) vs LR-PC 7.99 [7.45;8.59]⁄
Accuracy vs logloss
SVM-PC: acc vs ll 0.05 [0.14;0.05]
SVM-BT: acc vs ll 0.13 [0.01;0.25]
NSC: acc vs ll 0.22 [0.17;0.29]
kNN: acc vs ll 0.47 [0.33;0.63]
NB: acc vs ll 3.44 [2.59;4.20]
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mated (Table 3). Most models showed an ECI close to zero, excep-
tions based on accuracy were kNN, NB, and NSC (Table 3). Logistic
regression had the best ECI. Ranking models based on mean cali-
bration or ECI yields different results, which is explained by the
fact that these measures do not capture the same information. In
general terms the mean calibration measures calibration on the
group level whereas ECI focuses on the individual level. For exam-
ple, kNN based on logloss has relatively poor mean calibration but
a relatively good ECI.
The calibration plots for logistic regression (lowest ECI) and NB
(highest ECI) are shown in Fig. 2a–b. We have plotted the curves
for the risk of a benign tumor and for the risk of malignancy, even
though plotting only one would be sufﬁcient because both curves
are complementary. The reason we have shown both curves is to
make the plots consistent with the calibration plots for multiclass
models, where it is convenient to show curves for every category. It
is interesting to observe that the ECI value of 1.67 for NB corre-
sponded to calibration curves that are very deviant from the (ideal)
diagonal line. Although 1.67 appears close to 0, the NB model is not
well calibrated.
For SVM and kNN, different hyperparameters were selected
when relying on logloss vs accuracy as a selection criterion. As
expected, models based on logloss showed better calibration. This
is illustrated in Fig. 2c–d for kNN. A similar yet less explicit differ-
ence was observed for SVM.
4.2. Multiclass outcome
For all machine learning approaches except RF, hyperparameter
values obtained by maximizing accuracy were different from the
values obtained by minimizing logloss resulting in different risk
probabilities.
The best multiclass AUC results were obtained for the logistic
regression models (0.790–0.798) and RF (0.792), the worst for
kNN (0.684–0.686) (Table 4). Regarding pairwise AUCs (Table S1),
it was clear that it was most difﬁcult to distinguish between
borderline and stage I cancer, and between the different types ofinvasive cancers (stage I, stage II–IV, and secondary metastatic
cancer).
Overall the logistic regression approaches had the best mean
calibration, while NB was clearly worse, speciﬁcally when accuracy
was used to tune the hyperparameter (Table S2). This is remark-
able given that the available data were randomly split into devel-
opment and validation sets. For the other models the deviation
was mild (up to 4%). The ECI was lowest for the logistic regression
approaches (0.26–0.30) and kNN based on logloss (0.28), and high-
est for NB (4.82 when based on logloss, 8.25 when based on accu-
racy) (Table 4). When comparing the ECI of the best model LR-PC
with those of every other model, with the application of a Holm-
based step-down method to correct for multiple testing, we con-
clude that there is no statistically signiﬁcant difference between
the ECI of LR-PC and the ECI’s of MLR, LR-BT, SVM-BT based on
logloss, kNN based on logloss, and RF (Table 5). The other models’
ECI was signiﬁcantly lower.
The multiclass calibration plots of the best calibrated models
according to ECI (LR-PC as the best logistic regression model,
SVM-BT based on logloss as the best SVM model, RF, and kNN
based on logloss) are shown in Fig. 3. As highlighted in Section 2,
contrary to the calibration plots for binary outcomes, there is no
one-to-one relationship between predicted and observed probabil-
ities. For that reason we added spline smoothers to summarize the
trend. In Fig. 4 simpliﬁed calibration plots with only the smoothed
curves are shown. All models are fairly well calibrated. The most
clear deviation is that higher estimated risks for the small catego-
ries (borderline, stage I cancer, secondary metastatic cancer) are
typically too extreme (overﬁtted) as the curves for these outcome
categories deviate more from the diagonal as the predicted proba-
bility increases.
The ECI was always lower when hyperparameter tuning was
based on logloss compared with accuracy, except for SVM-PC
where results were nearly identical for both methods (Table 4).
For four algorithms (SVM-BT, kNN, NSC, NB), the 95% conﬁdence
interval on the ECI difference did not include 0 (Table 5). Even if
we were to correct for multiple testing, signiﬁcant differences
would remain except for SVM-BT. Hence minimization of logloss
resulted in better calibration, which is illustrated for kNN and NB
in Fig. 5. This ﬁgure also shows the clear miscalibration of risks
based on NB, even when logloss was used.5. Discussion
When validating a risk model for medical applications, discrim-
ination as well as calibration should be assessed [1–6]. The model
needs to be able to distinguish the different outcome categories
but also to reliably predict the risk of a certain outcome. In this
paper we have described a generic recalibration framework to
visualize and quantify the lack of calibration for multiclass risk
models irrespective of the modeling approach used. To illustrate
this we have used the diagnosis of ovarian tumors as a case study.
Different models were developed and validated with respect to dis-
crimination and calibration: logistic regression, support vector
machines, k nearest neighbors, random forest, naive Bayes and
nearest shrunken centroids. Overall, logistic regression and ran-
dom forest models showed the best calibration, whereas the cali-
bration of naive Bayes was disappointing. An explanation for the
latter might be that the independence assumption is unrealistic
for the data leading to inaccurate estimates [55].5.1. Visualization vs quantiﬁcation of calibration
The recalibration frameworkwas used to visualize calibration by
means of a calibration plot as well as to quantify the lack of calibra-
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Fig. 3. Multiclass calibration plot with smoother of the validation data for (a) pairwise coupling logistic regression model, (b) binary tree support vector machines with
logloss as optimization method, (c) random forest and (d) k nearest neighbors with logloss as optimization method.
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on calibration of individual patient risks, and therefore has an
advantage over mean calibration, which is a group level measure.
Mean calibration assesses whether estimated event rates are accu-
rate. Lack of mean calibration is also captured by ECI, but ECI cap-
tures other aspects as well such as over-ﬁtting (risk estimates that
are too extreme).
Both visualization and quantiﬁcation have their advantages and
disadvantages. Calibration plots are more informative and inter-
pretable than ECI, because ECI summarizes the calibration plot
for every outcome into a single number. Therefore, for the evalua-
tion of a single model one should focus on calibration plots. The ECI
should not be used as a stand-alone metric in this situation
because the result is hard to interpret without corresponding plots.
The well-known Hosmer–Lemeshow goodness-of-ﬁt test and its
extensions are often used to evaluate miscalibration of a single
model. Hosmer–Lemeshow statistics were not discussed in this
paper due to reported drawbacks with their use such as instability,
low power, sensitivity to sample size and arbitrariness of the con-
struction of subgroups [56,57]. If the aim is to compare multiple
models, however, ECI can be used. Given that ECI compares pre-
dicted probabilities with observed probabilities that are in factestimated, we advise bootstrapping to obtain conﬁdence intervals
or to test for a statistically signiﬁcant difference between models.
We always have to keep in mind that two models with the same
ECI may have different calibration curves and thus a different type
of miscalibration.
Since there is no one-to-one relationship between predicted and
observedprobabilities for themulticlass calibration plots (see Fig. 3)
we use smoothed curves to visualize the general relationship. If only
the smoothedcurves are shown (aswedid in Figs. 4 and5 for clarity),
information is lost. Nevertheless, we believe these smoothed rela-
tionship is most important in the assessment of calibration perfor-
mance. Yet if this relationship is good, meaning that it is close to
the diagonal line, it is still possible that predicted and observed
probabilities are away from the diagonal line for many patients. So
far, it is our experience that it is very difﬁcult to develop a model
where, the result for every patient in a validation dataset is close
to the diagonal line. Further research on this issue is needed.
5.2. Tuning: Logistic regression vs machine learning
The tuning of risk prediction models is an important issue [26].
For logistic regression, variable selection, non-linear effects and
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Fig. 4. Smoothed multiclass calibration plot of the validation data for (a) pairwise coupling logistic regression model, (b) binary tree support vector machines with logloss as
optimization method, (c) random forest and (d) k nearest neighbors with logloss as optimization method.
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investigated the inclusion of non-linear effects or interactions,
although non-linear effects are probably present [58]. In real clin-
ical applications such tuning is advised, for example by modeling
continuous predictors using spline functions, however the amount
of tuning should depend on the sample size that is available [58].
Machine learning approaches have different tuning parameters
(e.g. number of neighbors for kNN and number of considered vari-
ables in each split for RF) [26]. The choice of optimization method
for these hyperparameters may inﬂuence model performance [31].
As expected, we noticed in our study that considering logloss as an
optimization method for tuning resulted in better calibration com-
pared with accuracy. We acknowledge that other optimization
methods can be considered and may yield different model perfor-
mance [31].
5.3. Choice of algorithms
In the literature, many machine-learning models are available
and the optimal hyperparameter values of these models can be
obtained using different optimization techniques. Different meth-
ods can be used to create probabilities, certainly for multiclassoutcomes [25,28]. This results in a plethora of possible algorithms
to develop binary and multiclass risk models. In this paper we con-
sidered some approaches as an illustration of the multiclass cali-
bration tools that may be used. We did not attempt to compare
algorithms with respect to their capacity to produce calibrated risk
estimates. The latter would be of interest, but to do this we believe
that a large benchmark study would be required to compare a large
battery of algorithms on multiple datasets.
5.4. Further practical limitations
We compared different degrees of freedom for the vector
splines in the vector spline MLR analysis, and concluded that 2
degrees of freedom were sufﬁcient [15]. Procedures for automatic
selection of the level of smoothing for the calibration plots, for
example by using generalized cross validation, would be desirable
[59].
We randomly divided the data into development and valida-
tion data, with stratiﬁcation for the multiclass outcome. This ran-
dom split allowed the construction of calibration plots, but the
results may depend on the split. However we expect that the
dependency is limited due to the large sample size. Also, in real
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Fig. 5. Smoothed multiclass calibration plot of the validation data for k nearest neighbors (a–b) and naive Bayes (c–d) with accuracy and logloss as optimization method.
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dataset, for example by using new data collected later in time
or data from different hospitals. An advantage of using such a
random split is that it should lead to few problems with mean
calibration, because the development and validation are two
random samples from an identical population. Miscalibration in
our case study was more likely to be related to over-ﬁtting.
Another limitation is that we decided to use single imputation
for CA125. This approach ignores the fact that we are uncertain
about whether the imputed values are correct [42]. An alternative
to deal with the issue of uncertainty would be multiple imputa-
tion [42]. However, since the aim of this study was not the devel-
opment of risk prediction models for clinical practice, we made a
pragmatic decision to use single imputation.
5.5. General conclusions
The generic recalibration framework is an interesting approach
to visualizing the reliability of predicted risks and quantify lack of
calibration. The estimated calibration index (ECI) is easy for
comparing models, but is less informative and interpretable than
calibration plots.Acknowledgments
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